Reuters logo
BRIEF-Nuvectra corp says effective Aug. 31, co entered into amended and restated development agreement with Aleva Neurotherapeutics - SEC filing
September 5, 2017 / 1:47 PM / 3 months ago

BRIEF-Nuvectra corp says effective Aug. 31, co entered into amended and restated development agreement with Aleva Neurotherapeutics - SEC filing

Sept 5 (Reuters) - Nuvectra Corp

* Nuvectra Corp - effective august 31, co entered into amended and restated development agreement with Aleva Neurotherapeutics, S.A - SEC filing

* Nuvectra corp - agreement amends and restates terms of development agreement between Aleva and Nuvectra, dated January 29, 2016

* Nuvectra Corp-Aleva and Nuvectra agree to collaborate on development of deep brain stimulation product that may be used to treat Parkinson’s disease

* Nuvectra Corp - Aleva will pay nuvectra monthly for all services it provides on a time and material basis, as invoiced by Nuvectra Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below